IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 214 filers reported holding IMMUNOGEN INC in Q4 2020. The put-call ratio across all filers is 0.99 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $54,000 | -21.7% | 15,000 | 0.0% | 0.02% | -25.0% |
| Q2 2020 | $69,000 | +35.3% | 15,000 | 0.0% | 0.02% | +26.3% |
| Q1 2020 | $51,000 | -33.8% | 15,000 | 0.0% | 0.02% | -26.9% |
| Q4 2019 | $77,000 | +113.9% | 15,000 | 0.0% | 0.03% | +100.0% |
| Q3 2019 | $36,000 | +9.1% | 15,000 | 0.0% | 0.01% | +8.3% |
| Q2 2019 | $33,000 | -19.5% | 15,000 | 0.0% | 0.01% | -20.0% |
| Q1 2019 | $41,000 | -43.1% | 15,000 | 0.0% | 0.02% | -50.0% |
| Q4 2018 | $72,000 | -49.3% | 15,000 | 0.0% | 0.03% | -47.4% |
| Q3 2018 | $142,000 | -2.7% | 15,000 | 0.0% | 0.06% | -9.5% |
| Q2 2018 | $146,000 | -7.6% | 15,000 | 0.0% | 0.06% | -8.7% |
| Q1 2018 | $158,000 | +64.6% | 15,000 | 0.0% | 0.07% | +64.3% |
| Q4 2017 | $96,000 | -16.5% | 15,000 | 0.0% | 0.04% | -19.2% |
| Q3 2017 | $115,000 | +7.5% | 15,000 | 0.0% | 0.05% | 0.0% |
| Q2 2017 | $107,000 | – | 15,000 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 600,000 | $3,870,000 | 2.25% |
| CM Management, LLC | 375,000 | $2,419,000 | 2.24% |
| Consonance Capital Management LP | 3,515,944 | $22,678,000 | 2.12% |
| RA Capital Management | 18,417,458 | $118,793,000 | 1.66% |
| Kercheville Advisors, LLC | 244,421 | $1,564,000 | 0.85% |
| Redmile Group, LLC | 10,528,179 | $67,907,000 | 0.82% |
| Birchview Capital, LP | 190,000 | $1,226,000 | 0.71% |
| QVT Financial LP | 1,375,900 | $8,875,000 | 0.49% |
| Fernwood Investment Management, LLC | 149,340 | $963,000 | 0.38% |
| TWIN FOCUS CAPITAL PARTNERS, LLC | 104,068 | $671,000 | 0.21% |